The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review

Standard

The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review. / Schmidt, Rose A; Genois, Rosalie; Jin, Jonathan; Vigo, Daniel; Rehm, Jürgen; Rush, Brian.

in: DRUG ALCOHOL DEPEN, Jahrgang 228, 109065, 01.11.2021.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

APA

Vancouver

Bibtex

@article{2ec855bb858d458f9aebe181695cdd15,
title = "The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review",
abstract = "BACKGROUND: The aim of this paper was to examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems.METHOD: A systematic review of literature published up to March 2021 was conducted to summarize changes in prevalence, incidence, and severity of substance use associated with COVID-19 and the accompanying public health measures, including lockdown, stay-at-home orders, and social distancing.RESULTS: We identified 53 papers describing changes to substance use at the population level. The majority of papers described changes related to alcohol use and most relied on self-reported measures of consumption during the COVID-19 pandemic, compared with pre-pandemic use. There was less evidence to support changes in non-alcohol substance use. In general, risky pre-pandemic alcohol use, caregiving responsibilities, stress, depression, anxiety, and current treatment for a mental disorder were found to be associated with increased substance use.CONCLUSION: This review provides preliminary data on changes in substance use, indicating that certain segments of the population increased their alcohol use early on in the COVID-19 pandemic and may be at greater risk of harm and in need of additional services. There is a need for additional population-level information on substance use to inform evidence-based rapid responses from a treatment system perspective.",
keywords = "COVID-19, Communicable Disease Control, Humans, Incidence, Pandemics, Pharmaceutical Preparations, Prevalence, SARS-CoV-2",
author = "Schmidt, {Rose A} and Rosalie Genois and Jonathan Jin and Daniel Vigo and J{\"u}rgen Rehm and Brian Rush",
note = "Copyright {\textcopyright} 2021 Elsevier B.V. All rights reserved.",
year = "2021",
month = nov,
day = "1",
doi = "10.1016/j.drugalcdep.2021.109065",
language = "English",
volume = "228",
journal = "DRUG ALCOHOL DEPEN",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review

AU - Schmidt, Rose A

AU - Genois, Rosalie

AU - Jin, Jonathan

AU - Vigo, Daniel

AU - Rehm, Jürgen

AU - Rush, Brian

N1 - Copyright © 2021 Elsevier B.V. All rights reserved.

PY - 2021/11/1

Y1 - 2021/11/1

N2 - BACKGROUND: The aim of this paper was to examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems.METHOD: A systematic review of literature published up to March 2021 was conducted to summarize changes in prevalence, incidence, and severity of substance use associated with COVID-19 and the accompanying public health measures, including lockdown, stay-at-home orders, and social distancing.RESULTS: We identified 53 papers describing changes to substance use at the population level. The majority of papers described changes related to alcohol use and most relied on self-reported measures of consumption during the COVID-19 pandemic, compared with pre-pandemic use. There was less evidence to support changes in non-alcohol substance use. In general, risky pre-pandemic alcohol use, caregiving responsibilities, stress, depression, anxiety, and current treatment for a mental disorder were found to be associated with increased substance use.CONCLUSION: This review provides preliminary data on changes in substance use, indicating that certain segments of the population increased their alcohol use early on in the COVID-19 pandemic and may be at greater risk of harm and in need of additional services. There is a need for additional population-level information on substance use to inform evidence-based rapid responses from a treatment system perspective.

AB - BACKGROUND: The aim of this paper was to examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems.METHOD: A systematic review of literature published up to March 2021 was conducted to summarize changes in prevalence, incidence, and severity of substance use associated with COVID-19 and the accompanying public health measures, including lockdown, stay-at-home orders, and social distancing.RESULTS: We identified 53 papers describing changes to substance use at the population level. The majority of papers described changes related to alcohol use and most relied on self-reported measures of consumption during the COVID-19 pandemic, compared with pre-pandemic use. There was less evidence to support changes in non-alcohol substance use. In general, risky pre-pandemic alcohol use, caregiving responsibilities, stress, depression, anxiety, and current treatment for a mental disorder were found to be associated with increased substance use.CONCLUSION: This review provides preliminary data on changes in substance use, indicating that certain segments of the population increased their alcohol use early on in the COVID-19 pandemic and may be at greater risk of harm and in need of additional services. There is a need for additional population-level information on substance use to inform evidence-based rapid responses from a treatment system perspective.

KW - COVID-19

KW - Communicable Disease Control

KW - Humans

KW - Incidence

KW - Pandemics

KW - Pharmaceutical Preparations

KW - Prevalence

KW - SARS-CoV-2

U2 - 10.1016/j.drugalcdep.2021.109065

DO - 10.1016/j.drugalcdep.2021.109065

M3 - SCORING: Review article

C2 - 34600257

VL - 228

JO - DRUG ALCOHOL DEPEN

JF - DRUG ALCOHOL DEPEN

SN - 0376-8716

M1 - 109065

ER -